Towa Pharmaceutical Co Performance
| TWAPFDelisted Stock | USD 16.83 0.00 0.00% |
The entity has a beta of -1.97, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Towa Pharmaceutical are expected to decrease by larger amounts. On the other hand, during market turmoil, Towa Pharmaceutical is expected to outperform it. Towa Pharmaceutical right now has a risk of 0.0%. Please validate Towa Pharmaceutical standard deviation, as well as the relationship between the maximum drawdown and day median price , to decide if Towa Pharmaceutical will be following its existing price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Towa Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Towa Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Quick Ratio | 1.22 | |
| Fifty Two Week Low | 24.35 | |
| Payout Ratio | 7.30% | |
| Fifty Two Week High | 53.00 | |
| Trailing Annual Dividend Yield | 188.91% |
Towa |
Towa Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 1,683 in Towa Pharmaceutical Co on September 30, 2025 and sell it today you would earn a total of 0.00 from holding Towa Pharmaceutical Co or generate 0.0% return on investment over 90 days. Towa Pharmaceutical Co is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Towa, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Towa Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Towa Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Towa Pharmaceutical Co, and traders can use it to determine the average amount a Towa Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| TWAPF |
Based on monthly moving average Towa Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Towa Pharmaceutical by adding Towa Pharmaceutical to a well-diversified portfolio.
Towa Pharmaceutical Fundamentals Growth
Towa Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Towa Pharmaceutical, and Towa Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Towa Pink Sheet performance.
| Return On Equity | 14.4 | |||
| Return On Asset | 5.47 | |||
| Profit Margin | 10.43 % | |||
| Operating Margin | 13.20 % | |||
| Current Valuation | 56.49 B | |||
| Shares Outstanding | 49.21 M | |||
| Price To Earning | 8.48 X | |||
| Price To Book | 0.01 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 162.51 B | |||
| EBITDA | 31.73 B | |||
| Cash And Equivalents | 24.39 B | |||
| Cash Per Share | 495.57 X | |||
| Total Debt | 79.68 B | |||
| Debt To Equity | 0.63 % | |||
| Cash Flow From Operations | 20.79 B | |||
| Earnings Per Share | 2.87 X | |||
About Towa Pharmaceutical Performance
By analyzing Towa Pharmaceutical's fundamental ratios, stakeholders can gain valuable insights into Towa Pharmaceutical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Towa Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Towa Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Osaka, Japan. Towa Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 3456 people.Things to note about Towa Pharmaceutical performance evaluation
Checking the ongoing alerts about Towa Pharmaceutical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Towa Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Towa Pharmaceutical is not yet fully synchronised with the market data | |
| Towa Pharmaceutical has a very high chance of going through financial distress in the upcoming years | |
| About 48.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Towa Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Towa Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Towa Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Towa Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Towa Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Towa Pharmaceutical's pink sheet. These opinions can provide insight into Towa Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Towa Pink Sheet
If you are still planning to invest in Towa Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Towa Pharmaceutical's history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |